Analysis of clinicopathological features of 68 cases of malignant pleural mesothelioma
10.3760/cma.j.cn121094-20220425-00221
- VernacularTitle:68例恶性胸膜间皮瘤组织临床病理特征分析
- Author:
Wen MEI
1
;
Shengjie YANG
;
Yepin ZHANG
;
Qunshan FU
;
Wei XIONG
;
Yi ZHAO
Author Information
1. 楚雄彝族自治州第一人民医院病理科，楚雄 675000
- Keywords:
Malignant pleural mesothelioma;
Clinical features;
Diagnosis;
Immunohistochemistry
- From:
Chinese Journal of Industrial Hygiene and Occupational Diseases
2023;41(8):588-593
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinicopathological characteristics of diffuse malignant pleural mesothelioma (MPM), and explore the diagnostic methods in order to improve the early diagnosis rate.Methods:In January 2019 to January 2022, the clinical features, auxiliary examination and immunohistochemical results of 68 cases of MPM were analyzed retrospectively. The pathogenic features, histopathological morphology and the expression of related antibodies including Calretinin (CR), D2-40 and WT-1 were summarized.Results:Among the 68 patients, 40 male (58.82%), 28 female (41.18%), male to female ratio was 1.43%, median age was 58 years old; 50% of patients in Dayao County, epithelial mesothelioma 59 cases (86.76%), occurred in right chest in 39 cases (57.35%), left chest in 25 cases (36.76%), and 4 cases in both sides (5.89%). The most common initial clinical manifestations were pleural effusion (95.59%), chest pain (36.75%), chest tightness and shortness of breath (30.88%). The main imaging findings were pleural effusion in 49 cases (98.00%) and pleural thickening in 46 cases (92.00%). MPM tumor cells often expressed Calretinin, CK5/6, WT1 and D2-40, while TTF-1, NapsinA and CEA, the main markers differentiated from lung adenocarcinoma were negative. Serum CYFRA21-1 and CEA have high value in differential diagnosis of benign and malignant pleural effusions.Conclusion:Diffuse MPM has diverse histological and cytological morphology, which needs to be differentiated from a variety of diseases. Correct diagnosis of diffuse MPM through immunohistochemistry requires the combined application of a group of Mesothelium related antibodies.
